4. The infusion solution must be administered over a period of not less than 2 hours and must use an infusion set with an in-line, sterile,non-pyrogenic, low-protein-binding filter (pore size of 1.2 µm or less). Any unused portion of the infusion solution should not be storedfor reuse. 5. No physical biochemical compatibility studies have been conducted to evaluate the co-administration of REMICADE with other agents.REMICADE should not be infused concomitantly in the same intravenous line with other agents.6. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. If visibly opaque particles, discoloration, or other foreign particulates are observed, the solution should not be used. Storage Store the lyophilized product under refrigeration at 2ºC to 8ºC (36ºF to 46ºF). Do not freeze. Do not use beyond the expiration date. This product contains no preservative. | ||||
Email this article
Printer friendly
Bookmark this pageadvertisement
